Published in Crit Care Med on December 01, 2004
Coagulation abnormalities in critically ill patients. Crit Care (2006) 1.84
Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev (2013) 1.72
Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69
Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PLoS One (2013) 1.67
A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care (2013) 1.67
Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis. Crit Care (2012) 1.52
Low plasma D-dimer concentration predicts the absence of traumatic brain injury in children. J Trauma (2010) 1.50
Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study. Crit Care (2011) 1.39
Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J (2006) 1.10
Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology (2010) 1.10
Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care (2010) 1.06
Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit Care (2010) 1.00
Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness. PLoS One (2011) 0.96
Consumptive coagulopathy in angiosarcoma: a recurrent phenomenon? Sarcoma (2014) 0.96
Relationship between extravascular lung water and severity categories of acute respiratory distress syndrome by the Berlin definition. Crit Care (2013) 0.94
What factor within the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) criteria is most strongly correlated with trauma induced DIC? A retrospective study using thromboelastometry in a single center in Japan. Eur J Trauma Emerg Surg (2017) 0.91
A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J (2015) 0.90
Mannose-binding lectin and the balance between immune protection and complication. Expert Rev Anti Infect Ther (2011) 0.89
Disseminated intravascular coagulation or extended intravascular coagulation in massive pulmonary embolism. J Thromb Haemost (2010) 0.85
Disseminated intravascular coagulation. Indian J Anaesth (2014) 0.84
Sepsis and disseminated intravascular coagulation. J Intensive Care (2016) 0.84
Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock. Crit Care (2015) 0.84
Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients. Clinics (Sao Paulo) (2009) 0.83
Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J (2016) 0.82
Prostate cancer: beware of disseminated intravascular coagulation. BMJ Case Rep (2015) 0.81
Kasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literature. Int J Clin Exp Med (2015) 0.80
Clinical implications of a validated scoring system for disseminated intravascular coagulation. Crit Care Med (2004) 0.80
Thromboelastometry (TEM) findings in disseminated intravascular coagulation in a pig model of endotoxinemia. Mol Med (2010) 0.80
Comparison of Procedure-Based and Diagnosis-Based Identifications of Severe Sepsis and Disseminated Intravascular Coagulation in Administrative Data. J Epidemiol (2016) 0.79
DIC score in pregnant women--a population based modification of the International Society on Thrombosis and Hemostasis score. PLoS One (2014) 0.79
The inflammation-coagulation axis as an important intermediate pathway in acute lung injury. Crit Care (2008) 0.79
Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis. Surgery (2014) 0.79
The thromboelastometric discrepancy between septic and trauma induced disseminated intravascular coagulation diagnosed by the scoring system from the Japanese association for acute medicine. Medicine (Baltimore) (2016) 0.78
What's new in the diagnostic criteria of disseminated intravascular coagulation? Intensive Care Med (2016) 0.77
Another step in improving the diagnosis of disseminated intravascular coagulation in sepsis. Crit Care (2013) 0.77
Asphyxia by Drowning Induces Massive Bleeding Due To Hyperfibrinolytic Disseminated Intravascular Coagulation. Crit Care Med (2015) 0.77
Clinical assessment of trauma-induced coagulopathy and its contribution to postinjury mortality: A TACTIC proposal. J Trauma Acute Care Surg (2015) 0.75
Novel antibody against a glutamic acid-rich human fibrinogen-like protein 2-derived peptide near Ser91 inhibits hfgl2 prothrombinase activity. PLoS One (2014) 0.75
Acute Warfarin Toxicity as Initial Manifestation of Metastatic Liver Disease. Case Rep Crit Care (2016) 0.75
On the evaluation of the ISTH score for overt disseminated intravascular coagulation. Crit Care Med (2005) 0.75
The prothrombin time point of the disseminated intravascular coagulation score. Crit Care Med (2005) 0.75
PEAR1 gene polymorphism in a Chinese pedigree with pulmonary thromboembolism. Medicine (Baltimore) (2016) 0.75
Retrospective Evaluation of New Chinese Diagnostic Scoring System for Disseminated Intravascular Coagulation. PLoS One (2015) 0.75
Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients. Am J Clin Pathol (2013) 0.75
Can serum ferritin level predict disease severity in patients with crimean-congo hemorrhagic Fever? Eurasian J Med (2013) 0.75
Performance Evaluation of Five Different Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Predicting Mortality in Patients with Complicated Sepsis. J Korean Med Sci (2016) 0.75
Comparison of Two Diagnostic Scores of Disseminated Intravascular Coagulation in Pregnant Women Admitted to the ICU. PLoS One (2016) 0.75
Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation. Ann Lab Med (2016) 0.75
New-onset acute thrombocytopenia in hospitalized patients: pathophysiology and diagnostic approach. J Community Hosp Intern Med Perspect (2017) 0.75
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation (2011) 6.47
Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet (2011) 4.78
Prevention and treatment of major blood loss. N Engl J Med (2007) 4.72
Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma (2008) 3.40
Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med (2006) 3.13
Association Between Arterial Hyperoxia and Outcome in Subsets of Critical Illness: A Systematic Review, Meta-Analysis, and Meta-Regression of Cohort Studies. Crit Care Med (2015) 2.96
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet (2003) 2.86
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol (2010) 2.75
Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med (2006) 2.75
Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care (2008) 2.74
The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis. J Am Coll Cardiol (2003) 2.71
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med (2013) 2.68
Temporal abstraction for feature extraction: a comparative case study in prediction from intensive care monitoring data. Artif Intell Med (2007) 2.66
Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors. J Clin Oncol (2002) 2.55
Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res (2005) 2.46
Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol (2007) 2.46
KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood (2006) 2.41
Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock (2009) 2.26
Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology (2006) 2.19
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood (2010) 2.14
A comparison of the performance of a model based on administrative data and a model based on clinical data: effect of severity of illness on standardized mortality ratios of intensive care units. Crit Care Med (2012) 2.13
Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med (2005) 2.12
Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood (2010) 2.04
Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood (2008) 2.03
Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes (2006) 1.97
Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension (2008) 1.95
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res (2006) 1.95
Management of adult Jehovah's Witness patients with acute bleeding. Am J Med (2009) 1.89
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood (2007) 1.86
Proteomic analysis of high-density lipoprotein. Proteomics (2006) 1.82
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med (2006) 1.82
Clinicians' response to hyperoxia in ventilated patients in a Dutch ICU depends on the level of FiO2. Intensive Care Med (2010) 1.77
β₂-glycoprotein I: a novel component of innate immunity. Blood (2011) 1.75
Cardiac output response to norepinephrine in postoperative cardiac surgery patients: interpretation with venous return and cardiac function curves. Crit Care Med (2013) 1.73
Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology (2010) 1.72
New fundamentals in hemostasis. Physiol Rev (2013) 1.70
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial. Blood (2003) 1.70
Struggle for implementation of new strategies in intensive care medicine: anticoagulation, insulin, and lower tidal volumes. J Crit Care (2005) 1.66
Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol (2009) 1.65
Effect of changes over time in the performance of a customized SAPS-II model on the quality of care assessment. Intensive Care Med (2011) 1.65
Quality of data collected for severity of illness scores in the Dutch National Intensive Care Evaluation (NICE) registry. Intensive Care Med (2002) 1.63
The impact of different prognostic models and their customization on institutional comparison of intensive care units. Crit Care Med (2007) 1.62
Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol (2006) 1.62
Prediction of long-term mortality in ICU patients: model validation and assessing the effect of using in-hospital versus long-term mortality on benchmarking. Intensive Care Med (2013) 1.61
Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation. Blood (2008) 1.61
Time course of platelet counts in critically ill patients. Crit Care Med (2002) 1.60
Mortality after hospital discharge in ICU patients. Crit Care Med (2013) 1.60
Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol (2005) 1.60
Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats. Crit Care Med (2008) 1.58
Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion (2014) 1.58
Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide. Crit Care Med (2009) 1.55
Pulmonary activation of coagulation and inhibition of fibrinolysis after burn injuries and inhalation trauma. J Trauma (2011) 1.54
Determinants of mortality after hospital discharge in ICU patients: literature review and Dutch cohort study. Crit Care Med (2013) 1.54
Outcomes Associated With the Nationwide Introduction of Rapid Response Systems in The Netherlands. Crit Care Med (2015) 1.53
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood (2006) 1.52
Effectiveness and Clinical Outcomes of a Two-Step Implementation of Conservative Oxygenation Targets in Critically Ill Patients: A Before and After Trial. Crit Care Med (2016) 1.47
Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica (2009) 1.46
Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med (2008) 1.46
Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc (2008) 1.45
A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset. Crit Care (2008) 1.44
Dobutamine does not influence inflammatory pathways during human endotoxemia. Crit Care Med (2006) 1.44
Questionnaires on Family Satisfaction in the Adult ICU: A Systematic Review Including Psychometric Properties. Crit Care Med (2015) 1.43
Overexpression of activated protein C is detrimental during severe experimental gram-negative sepsis (melioidosis). Crit Care Med (2013) 1.43
How nurses and physicians judge their own quality of care for deteriorating patients on medical wards: self-assessment of quality of care is suboptimal*. Crit Care Med (2012) 1.43
The influence of volume and intensive care unit organization on hospital mortality in patients admitted with severe sepsis: a retrospective multicentre cohort study. Crit Care (2007) 1.43
Influence of entry criteria on mortality risk and number of eligible patients in recent studies on severe sepsis. Crit Care Med (2005) 1.43
Cytokines and acute phase response in delirium. J Psychosom Res (2007) 1.42
Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*. Crit Care Med (2012) 1.41
Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia. Thromb Haemost (2012) 1.40
Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother (2006) 1.40
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver. Blood (2010) 1.40
Performance of risk-adjusted control charts to monitor in-hospital mortality of intensive care unit patients: a simulation study. Crit Care Med (2012) 1.39
Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol (2002) 1.39
Postoperative pro-adrenomedullin levels predict mortality in thoracic surgery patients: comparison with Acute Physiology and Chronic Health Evaluation IV Score*. Crit Care Med (2015) 1.39
Geriatric conditions in acutely hospitalized older patients: prevalence and one-year survival and functional decline. PLoS One (2011) 1.39
Fluid loss does not explain coagulation activation during air travel. Thromb Haemost (2008) 1.38
Individual and Clustered Rankability of ICUs According to Case-Mix-Adjusted Mortality. Crit Care Med (2016) 1.38
Factors that predict outcome of intensive care treatment in very elderly patients: a review. Crit Care (2005) 1.37
Tissue factor and coronary artery disease. Cardiovasc Res (2002) 1.37
Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis (2004) 1.36
Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med (2005) 1.33
Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet (2002) 1.32
Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care (2006) 1.32
The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol (2009) 1.25
Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol (2005) 1.24
The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis (2011) 1.23
Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes (2006) 1.22
External validation of Acute Physiology and Chronic Health Evaluation IV in Dutch intensive care units and comparison with Acute Physiology and Chronic Health Evaluation II and Simplified Acute Physiology Score II. J Crit Care (2010) 1.22